Detalles de la búsqueda
1.
Causal inference for longitudinal data based on historical controls.
J Biopharm Stat
; 33(3): 289-306, 2023 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36469552
2.
Evaluation of alternative confidence intervals to address non-inferiority through the stratified difference between proportions.
Pharm Stat
; 20(1): 146-162, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32820592
3.
Design of randomized controlled confirmatory trials using historical control data to augment sample size for concurrent controls.
J Biopharm Stat
; 29(3): 558-573, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30612514
4.
Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2).
Drugs
; 81(17): 2017-2033, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34724172
5.
OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females.
Int Clin Psychopharmacol
; 35(1): 19-28, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31609787
6.
Reducing Patient Burden in Clinical Trials Through the Use of Historical Controls: Appropriate Selection of Historical Data to Minimize Risk of Bias.
Ther Innov Regul Sci
; 54(4): 850-860, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32557308
7.
Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose finding.
Contemp Clin Trials Commun
; 11: 83-88, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30003170
8.
Clinical Study Design to Assess Both Short- and Long-term Efficacy in Addition to Group Sequential Test on Safety.
Ther Innov Regul Sci
; 52(6): 690-695, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29714571
9.
Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials: Review of Methods and Opportunities.
Ther Innov Regul Sci
; 52(5): 546-559, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29909645
10.
Omalizumab is effective in the long-term control of severe allergic asthma.
Ann Allergy Asthma Immunol
; 91(2): 154-9, 2003 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12952109
11.
Omalizumab improves asthma-related quality of life in patients with severe allergic asthma.
J Allergy Clin Immunol
; 111(2): 278-84, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12589345
Resultados
1 -
11
de 11
1
Próxima >
>>